GBIO
Generation Bio Co. · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website generationbio.com
- Employees(FY) 150
- ISIN US37148K1007
Performance
+12.27%
1W
+16.93%
1M
+71.43%
3M
+226.79%
6M
+121.82%
YTD
-12.65%
1Y
Profile
Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was formerly known as Torus Therapeutics, Inc. and changed its name to Generation Bio Co. in November 2017. Generation Bio Co. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.
Technical Analysis of GBIO 2024-05-10
Overview:
In analyzing the technical indicators for GBIO over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key aspects, we aim to offer valuable insights and predictions to guide your invest...
Recent News & Updates
- 2024-05-13 09:54
- 2024-05-13 05:15
- 2024-05-13 04:05
- 2024-05-08 18:59
- 2024-05-03 22:49
Moderna, Inc. (NASDAQ:MRNA) Q1 2024 Earnings Call Transcript(Insidermonkey)
- 2024-04-22 05:31
- 2024-04-01 18:59
- 2024-03-07 15:32
- 2024-03-06 09:52
- 2024-03-06 04:40
- 2024-03-06 03:20
- 2024-02-26 17:59
- 2024-01-03 03:05
- 2023-12-05 14:05
- 2023-11-28 19:41
- 2023-11-28 17:59
- 2023-11-09 03:15
- 2023-10-25 18:59
- 2023-10-17 18:59
- 2023-09-18 19:30
- 2023-08-02 20:49
Insider Buyers Lose US$80k As Generation Bio Sheds US$37m(Yahoo Finance)
- 2023-08-02 19:30
- 2023-08-02 07:05
- 2023-08-02 04:15
Generation Bio Reports Second Quarter 2023 Financial Results(Yahoo Finance)
- 2023-05-30 19:30
- 2023-05-10 06:05
- 2023-05-10 04:15
- 2023-05-09 04:15
- 2023-04-10 19:30
- 2023-04-09 21:40
Page 1 of 4
previousnext